IGF1 and prostate carcinoma: To further explore the sources of heterogeneity in the association effect between serum IGF-I and the risk of prostate cancer, this study conducted meta-regression analyses using the mean age of study subjects and the mean serum IGF-I value as covariates (Figure 4).